Physician profile
Eric P Wilson
NPI 1114927597
$6,162.14
in general payments reported to CMS, 2019-2025
27 companies · $606 in 2025
The $606 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,081 · 2020: $231 · 2021: $1,110 · 2022: $1,606 · 2023: $873 · 2024: $655 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,002.74 | 2021-2022 | |
| Boston Scientific Corporation | $772.00 | 2019-2025 | Eluvia, Ranger, Jetstream Sc |
| Janssen Pharmaceuticals, INC | $547.46 | 2019-2024 | Xarelto |
| Abbott Laboratories | $357.65 | 2023-2025 | Perclose Prostyle, Emboshield Nav6 |
| Medtronic, INC. | $331.88 | 2021-2025 | Endurant Iis, Venaseal, Microstream |
| Amgen INC. | $322.59 | 2019-2024 | Repatha |
| Shockwave Medical, INC | $284.71 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bolton Medical INC | $270.87 | 2023-2025 | Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $223.59 | 2019-2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Novartis Pharmaceuticals Corporation | $205.36 | 2021-2024 | |
| Bard Peripheral Vascular, INC. | $179.03 | 2022-2025 | Rotarexs 6 F X 135 Cm |
| Abiomed | $96.77 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $89.82 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $84.52 | 2019-2024 | Eliquis |
| Smith+Nephew, INC. | $76.44 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $42.67 | 2019 | |
| Endologix LLC | $42.00 | 2022 | |
| Chiesi USA, INC. | $39.25 | 2020 | |
| Organogenesis INC. | $38.25 | 2019 | |
| Cook Medical LLC | $35.94 | 2022-2023 | Zilver Vena |
| Scpharmaceuticals INC. | $22.89 | 2024 | |
| Integra Lifesciences Corporation | $20.59 | 2019 | |
| Lemaitre Vascular, INC. | $16.39 | 2023 | Restoreflow |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.20 | 2019 | |
| Pfizer INC. | $14.86 | 2024 | |
| Kci USA, INC. | $14.82 | 2021 | |
| Allergan, INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.